Adaptimmune Therapeutics plc (ADAP)
NASDAQ: ADAP · Real-Time Price · USD
0.0714
-0.0069 (-8.76%)
Aug 14, 2025, 12:59 PM - Market open
ADAP's stock price has decreased by -93.27% in the past year and price targets may not have had time to catch up.
Adaptimmune Therapeutics Analyst Ratings
Total Analysts
6
Consensus Rating
Hold
Price Target
$1.02
Upside
+1,329.57%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jul 29, 2025 |
| Mizuho | Mizuho | Buy → Hold Downgrades $1.5 → $0.5 | Buy → Hold | Downgrades | $1.5 → $0.5 | +600.77% | Jun 26, 2025 |
| Barclays | Barclays | Sell Maintains $1 → $0.46 | Sell | Maintains | $1 → $0.46 | +544.71% | May 14, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $1.5 → $1 | Hold | Maintains | $1.5 → $1 | +1,301.54% | May 14, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $3.5 → $3 | Strong Buy | Maintains | $3.5 → $3 | +4,104.63% | Apr 1, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $3 → $1.75 | Strong Buy | Maintains | $3 → $1.75 | +2,352.70% | Mar 26, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $2 → $1.5 | Hold | Maintains | $2 → $1.5 | +2,002.31% | Mar 21, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $3.15 → $1.4 | Buy | Maintains | $3.15 → $1.4 | +1,862.16% | Mar 21, 2025 |
| Mizuho | Mizuho | Buy Maintains $3 → $1.5 | Buy | Maintains | $3 → $1.5 | +2,002.31% | Nov 27, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $3.5 | Strong Buy | Reiterates | $3.5 | +4,805.40% | Nov 19, 2024 |
| Guggenheim | Guggenheim | Strong Buy Maintains $4 → $3 | Strong Buy | Maintains | $4 → $3 | +4,104.63% | Nov 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $4 → $3.5 | Strong Buy | Maintains | $4 → $3.5 | +4,805.40% | Nov 14, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $4 | Strong Buy | Reiterates | $4 | +5,506.17% | Aug 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $4 | Strong Buy | Reiterates | $4 | +5,506.17% | Aug 5, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $4 | Strong Buy | Initiates | $4 | +5,506.17% | Jul 30, 2024 |
| Scotiabank | Scotiabank | Buy Initiates $3.15 | Buy | Initiates | $3.15 | +4,314.86% | May 30, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.